Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 44246
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
44246
Date of registration
29.03.1982
Company name
Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch
Revision date
Valid until
Indication
Date of market entry
Index Therapeuticus (BSV)
01.01.30.
Revocation Date
Index Therapeuticus (Swissmedic)
01.01.30.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
MST Continus 10 mg Tabletten retard
Coated tablets ()
N02AA01
CI
02
MST Continus 30 mg
Tabletten retard
Delayed release tablets (Morphine Sulfate Pentahydrate 30 mg)
N02AA01
CI
03
MST Continus 60 mg
Tabletten retard
Delayed release tablets (Morphine Sulfate Pentahydrate 60 mg)
N02AA01
CI
04
MST Continus 100 mg
Tabletten retard
Delayed release tablets (Morphine Sulfate Pentahydrate 100 mg)
N02AA01
CI
05
MST Continus 200 mg
Tabletten retard
Delayed release tablets (Morphine Sulfate Pentahydrate 200 mg)
N02AA01
CI
08
MST Continus 10 mg
Tabletten retard
Delayed release tablets (Morphine Sulfate Pentahydrate 10 mg)
N02AA01
CI
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
